Editorial
Editorial: refining the estimation of fitness for surgery
Abstract
Lung cancer is the second most common cancer in both men and women and remains the leading cause of cancer death worldwide. Non-small cell lung cancer (NSCLC) accounts for approximately 80% to 85% of new cases of lung cancer (1), with surgical resection serving as a potentially curative treatment for patients with early stage disease.